RU58841 is a non-steroidal antiandrogenic medication that was initially developed in the 1980s as a topical treatment remedy for acne and male pattern baldness – androgenetic alopecia. Overall, I would highly recommend Xi'an Lyphar Biotech, having tested them, their compound is solid and is far cheaper than mainstream options, allowing you to use more solution per day at a much higher concentration. This is my first post on any hairloss forum, i'm 23 and very slowly losing my hair density owing to high DHT sensitivity (still have a lot left though). I started using RU58841 last year from **. I was very impressed, however the cost was too high to be consistent enough with applications. RU58841 is a specific androgen receptor antagonist or a so called anti-androgen. This non steroidal topical androgen antagonist was investigated for therapeutic value in androgenetic alopecia and acne. In studies and clinical trials RU58841 has shown to;

I have found and tested a very low cost RU58841 supplier from China called Xi'an Lyphar Biotech Co., Ltd. These guys have found their way onto this forum a few times but I dont believe they have been tested as a supplier. RU58841 (RU-58841) works by binding to the androgen receptor in the hair follicle. Therefore androgens don’t have the chance to bind and start the chain reaction of androgenetic alopecia and begin the so called miniaturization process. It has been demonstrated to interrupt this hair loss message locally so that normal hair growth could continue. We at anageninc provide this compound in a unique stable route of synthesis form which is extremely stable in solid and solution form which has been demonstrated by our R&D laboratory. The results are very encouraging which shows that the current anageninc route of synthesis is stable for at least 24 months at room temperature. Product Information: We have historically focused on Androgen Receptor agonist compound research, but RU58841 is the first androgen receptor antagonist compound we have synthesized. In comparison to finasteride (which is a 5α-reductase inhibitor, inhibiting DHT on a systematic elvel), anagen follicles increased an average of 88% compared with dosing compared to 103% with dosing of RU58841 (5%).Since this medication is an anti-androgen, it may be able to target skin conditions such as acne and androgenic alopecia. However, the mechanism of RU58841 is entirely different from other anti-androgenic medications. And here is the reason: RU58841 is a nonsteroidal antiandrogen (NSAA) investigated for potential use as a topical treatment for androgen-dependent conditions including pattern hair loss.